Skip to search form
Skip to main content
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
N-anisoyl-GABA
National Institutes of Health
Create Alert
Related topics
Related topics
1 relation
Broader (1)
Anisoles
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Dihydroartemisinin and its Analogs: A New Class of Antitubercular Agents.
K. Kalani
,
V. Chaturvedi
,
Priyanka Trivedi
,
Sudeep Tondon
,
S. Srivastava
Current topics in medicinal chemistry
2019
Corpus ID: 73479514
BACKGROUND Tuberculosis is one of the leading causes of mortality worldwide. Resistance against the frontline anti-tubercular…
Expand
2006
2006
Hidden aconite poisoning: identification of yunaconitine and related aconitum alkaloids in urine by liquid chromatography-tandem mass spectrometry.
Chi-kong Lai
,
Wing-Tat Poon
,
Yan-wo Chan
Journal of analytical toxicology
2006
Corpus ID: 22185355
Poisoning from aconite occurs worldwide as a result of misuse of the potent plant. Laboratory investigation into suspected…
Expand
2003
2003
A Direct Synthesis of Nucleoside Analogs Homologated at the 3′‐ and 5′‐Positions
J. Schmidt
,
J. Schmidt
,
Bernd Eschgfäller
,
Bernd Eschgfäller
,
S. Benner
2003
Corpus ID: 31209524
A new route is presented to prepare analogs of nucleosides homologated at the 3′- and 5′-positions. This route, applicable to…
Expand
2001
2001
Aniracetam enhances cortical dopamine and serotonin release via cholinergic and glutamatergic mechanisms in SHRSP
M. Shirane
,
Kazuo Nakamura
Brain Research
2001
Corpus ID: 23949563
Aniracetam, a cognition enhancer, has been recently found to preferentially increase extracellular levels of dopamine (DA) and…
Expand
2000
2000
Group II metabotropic glutamate receptors are a common target of N-anisoyl-GABA and 1S,3R-ACPD in enhancing ACh release in the prefrontal cortex of freely moving SHRSP
M. Shirane
,
Kazuo Nakamura
Neuropharmacology
2000
Corpus ID: 44976290
Aniracetam is a therapeutically useful cognition enhancer for treating various neuropsychiatric symptoms occurring after cerebral…
Expand
2000
2000
Serotonergic mechanisms involved in the attentional and vigilance task performance of rats and the palliative action of aniracetam
K. Nakamura
,
M. Kurasawa
Naunyn-Schmiedeberg's Archives of Pharmacology
2000
Corpus ID: 12259729
Abstract. Central serotonergic systems play an important role in regulating mood/emotion, cognition, sleep and wakefulness…
Expand
1998
1998
Dynorphin A(6-12) Analogs Suppress Thermal Edema
E. Wei
,
H. A. Thomas
,
E. Gjerde
,
R. K. Reed
,
G. P. Vlasov
Peptides
1998
Corpus ID: 38837618
Dynorphin A (Dyn A) is a 17-residue opioid peptide derived from prodynorphin precursors found in mammalian tissues. Removal of…
Expand
1998
1998
Apomorphine-induced hypoattention in rats and reversal of the choice performance impairment by aniracetam.
K. Nakamura
,
M. Kurasawa
,
Y. Tanaka
European journal of pharmacology
1998
Corpus ID: 25247702
Aging-, disease- and medication-related imbalance of central dopaminergic neurons causes functional impairment of cognition and…
Expand
1990
1990
Determination of aniracetam and its main metabolite, N-anisoyl-GABA, in human plasma by high-performance liquid chromatography.
A. Guenzi
,
M. Zanetti
Journal of chromatography
1990
Corpus ID: 28204913
Two different reversed-phase high-performance liquid chromatographic methods for the determination of aniracetam (I) and its…
Expand
1987
1987
14 anisoyl Ako Nin and novel analgesic, anti-inflammatory agents that it as an active ingredient
村山 光雄
,
盛 孝男
1987
Corpus ID: 81239731
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE